Navigation Links
DavosLife: Vitamin E Tocotrienol Shows Increased Cancer Cell Apoptosis Without Toxicity in Phase 1 Pancreatic Cancer Trial
Date:5/30/2011

SINGAPORE, May 30, 2011 /PRNewswire-Asia/ -- Davos Life Science (DavosLife) has today announced preliminary results of a phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer. Tocotrienols are highly potent members of the Vitamin E family that have been found by researchers to inhibit the growth and survival of various types of cancer cells. This clinical trial revealed that Natural e3 was able to increase apoptosis (cell death) in pancreatic cancer tumours, with no toxicity. The study was carried out by researchers at The H. Lee Moffitt Cancer Center & Research Institute in Florida, United States, and supported by DavosLife and by the U.S. National Institute of Health. This data was presented by the Moffitt Cancer Center at the recent American Association for Cancer Research (AACR) Annual Meeting.

For a period of 2 weeks prior to surgery, 12 subjects received Natural e3, with 3 subjects at each dose level of 200 mg, 400 mg, 600 mg and 800 mg per day. This oral treatment occurred pre-surgery to examine the effect of Natural e3 on the resected pancreatic cancer tumour. To assess for toxicity, blood samples were collected pre-dose on day 1, day 8, on the day of the patients' surgery and 3-6 weeks post-surgery. This trial occurred between October 2009 and August 2010.

The Moffitt Cancer Center researchers, led by Dr Mokenge Malafa, found no adverse drug-related events in the patients and no change in the rate of post-operative complications at doses up to 800 mg per day. They also found that giving patients daily doses of Natural e3 greater than 200 mg increased apoptosis in the pancreatic tumours as well as increased expression of p27, an important kinase inhibitor involved in the regulation of the cell cycle. Reduced levels of p27 have been found in some types of cancers.

"Pancreatic cancer is a highly fatal form of cancer with average 5 year survival rates at less than 10%
'/>"/>

SOURCE Davos Life Science Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
2. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
3. Scientists Reveal Roadmap to Brain Health That Can Be Passed Down to Future Generations: Exercise, Omega-3, Folic Acid, Vitamin B6, and Vitamin B12
4. Emisphere Presents Dramatic Clinical Evidence Demonstrating New Approach to Vitamin B12 Supplementation
5. Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
6. Evidence Lacking in Multivitamin Study of Womens Risk of Cancer, Heart Disease or Death, Says Natural Products Association
7. Harvard Study Shows Folic Acid, B Vitamins in Animi-3(R) May Prevent Vision Loss
8. Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
9. Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
10. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
11. VitaminSpice Appoints Dr. Richard F. Seelig as Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Two ... increasing in applications as their effectiveness is ... Kalorama Information.  Kalorama Information says that while ... the most powerful tool in proteomic biomarker ... MS) through its traditional techniques has struggled ...
(Date:2/26/2015)... Ill. , Feb. 26, 2015  AbbVie ... 15 abstracts of studies in its neuroscience and ... during the 67 th American Academy of ... , from April 18-25. The accepted abstracts ... DUOPA, in addition to investigational treatments in AbbVie,s ...
(Date:2/26/2015)... 26, 2015  Mail-service and specialty pharmacies will ... and government health plans $23.3 billion over the ... Pharmaceutical Care Management Association (PCMA). "Home ... of the easiest ways to reduce health costs," ... . "Policymakers should resist efforts to restrict these ...
Breaking Medicine Technology:Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7PCMA: Report Shows High-Tech Specialty and Mail-Service Pharmacies Will Reduce Costs for Texas Employers, Consumers and Public Programs by $23.3 Billion 2
(Date:2/27/2015)... Victorian Hotel recently celebrated Valentine’s Day ... wanted to spend the auspicious day together. This Vancouver ... jump on Valentine’s Day with a sweet overnight package, ... their luxurious rooms. , The hotel started its ... a mouthwatering 3 course meal at Café 335. This ...
(Date:2/27/2015)... The UC Davis Huntington’s Disease Center, ... it a beacon of hope for people with Huntington’s ... by the national society committed to the values that ... of America — as a Level 1 Huntington’s Disease ... center’s service to over 300 families coping with Huntington's ...
(Date:2/27/2015)... “ Logical Operations ” was featured ... which takes a look at the latest and coolest ... a special reporter for NewsWatch and a technology expert, ... company helps companies avoid cyber security threats. , If ... see cyber security somewhere in the headlines. Well, cyber ...
(Date:2/27/2015)... Mirena IUD lawsuits ( http://www.mirenalawsuit2014.com/ ) ... perforations and other serious harm due to spontaneous migration ... in the multicounty litigation underway in New Jersey’s Bergen ... records indicate that the proceeding’s 34th Case Management Order ... that same day. (In Re: Mirena Litigation; Case No. ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Jupiter Medical ... pioneering partnership, Mount Sinai Heart New York at Jupiter ... research in South Florida. , “This innovative collaboration ... way we’re delivering unparalleled health care in our very ... Executive Officer of Jupiter Medical Center. “This kind of ...
Breaking Medicine News(10 mins):Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 2Health News:UC Davis Huntington's Disease Center Receives Level 1 Designation 3Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5
... 8-year-old boy,living with epilepsy, and his mother Amy receive ... the exclusive sponsor of Canine,Assistants seizure response dogs. Through ... to play sports, take,music lessons, and learn Tae Kwon ... when his parents are not around is still a ...
... quick, non-invasive identification of the dangerous disease , , WEDNESDAY, ... be able to accurately, rapidly, and non-invasively diagnose lung ... the mouth, a new study suggests. , Oral cavity ... to be a highly accurate indicator of similar lung ...
... Mass., April 16 Xceed Molecular, a ... analysis,systems, announced that the University of Florida ... work with primary researchers,Charles Joel Rosser, MD ... of Surgery), to perform initial verification and ...
... Required to Provide Calorie Information, ALEXANDRIA, Va., ... today,s federal court ruling upholding,a New York City ... content of foods on their menus and menu ... to the regulation filed by the New York ...
... MONICA, Calif., April 16 Consumer,Watchdog today joined ... lawsuit alleging that health insurer Blue Cross engaged ... insurance of patients,after they got sick., The ... at least hundreds,of patients who have been left ...
... 16 MedCath Corporation,(Nasdaq: MDTH ) announced today ... of Directors., Mr. Grossman brings a wealth of ... Directors. He served as partner and health care,practice leader ... years with the firm. While with Pricewaterhouse Coopers, he ...
Cached Medicine News:Health News:Young Boy With Epilepsy to Gain Independence With New Seizure Response Dog From Canine Assistants 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 2Health News:Mouth Swab May One Day Diagnose Lung Cancer 3Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 2Health News:Xceed Molecular Signs University of Florida to Strategic Collaborator Program; Focus on Developing New Molecular Test to Diagnose Early-Stage Bladder Cancer 3Health News:Statement of the American Diabetes Association Supporting Federal Court's Ruling on New York City Proposal 2Health News:Consumer Watchdog Applauds L.A. City Attorney's Efforts to Reinstate Cancelled Blue Cross Patients; Urges State HMO Regulator to Do Same 2Health News:Woodrin 'Woody' Grossman Appointed to MedCath's Board of Directors 2
... breadth of infectious disease ELISA products make ... standard assay protocols for faster integration into ... products provide increased reliability and run-to-run consistency. ... detection assays for a wide range of ...
... We offer a complete ... bringing laboratorians state-of-the-art monoclonal and ... the detection of enteric pathogens ... includes products for Clostridium difficile, ...
... The C. Difficile Tox A/B II ... Professional Diagnostics's exclusive Fecal-Quik-Prep device which greatly ... stool specimens for Tox A/B II testing. ... preparation/transfer device that greatly reduces the amount ...
... products for autoimmune testing feature single-well ANA ... as specific reflex tests including dsDNA, and ... (Ro), SS-B (La), Scl-70 and Jo-1. In ... full line of products for Cardiolipins (IgA, ...
Medicine Products: